A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.
Primary Sponsor
NCIC CTG
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
180
Trial Chairperson
International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua
Trial Contact
ymurray@ctg.queensu.ca
Clinical Trial Registration
Related Post
9 January, 2025
Tour de Cure grants support two valuable TROG trials
9 January 2025: Two important TROG Cancer Research trials
7 January, 2025
GenesisCare Foundation $300,000 donation to support TROG work
7 January 2025: TROG Cancer Research is advancing vital
